Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s13046-018-0894-0.

Title:
FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC | Journal of Experimental & Clinical Cancer Research
Description:
Background Accumulating evidence suggests that cancer stem cells (CSCs) play a critical role in tumor initiation, progression and therapy, and recent studies have indicated that Forkhead box C1 (FOXC1) is strongly associated with CSCs. This study investigates the regulatory effects of FOXC1 on CSC-like properties in non-small cell lung cancer (NSCLC). Methods We analyzed FOXC1 expression in NSCLC using the Cancer Genome Atlas (TCGA) database on UALCANC and performed survival analyses of NSCLC patients on Human Protein Atlas. CSC-like properties were analyzed based on CSC marker-positive cell population, self-renewal ability, stemness-related gene expression, tumorigenicity and drug resistance. The percentage of CD133+ cells was analyzed by flow cytometric analysis. Self-renewal ability was detected by sphere-formation analysis. Real-time PCR, western blotting and immunohistochemical staining were employed to detect mRNA and protein levels. Tumorigenicity was determined based on a xenograft formation assay, and effects of FOXC1 on drug resistance were assessed by cell viability and apoptosis assays. Luciferase reporter and chromatin immunoprecipitation (ChIP) assays were used to investigate the binding of FOXC1 to beta-catenin promoter. Results FOXC1 expression was found to be elevated in NSCLC tissues and negatively correlated with patient survival. FOXC1 knockdown reduced CD133+ cell percentage, suppressed self-renewal ability, decreased expression of stemness-related genes (Oct4, NANOG, SOX2 and ABCG2) and inhibited NSCLC cell tumorigenicity in vivo. Moreover, FOXC1 knockdown increased cisplatin and docetaxel sensitivity and reduced gefitinib resistance, whereas FOXC1 overexpression enhanced CSC-like properties. Luciferase reporter and ChIP assays showed beta-catenin to be a direct transcriptional target of FOXC1. Furthermore, overexpression of beta-catenin reversed the CSC-like property inhibition induced by FOXC1 knockdown, and knockdown of beta-catenin attenuated the CSC-like properties induced by FOXC1 overexpression. Conclusions This study demonstrates that FOXC1 induces CSC-like properties in NSCLC by promoting beta-catenin expression. The findings indicate that FOXC1 is a potential molecular target for anti-CSC-based therapies in NSCLC.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Science
  • Education
  • Health & Fitness

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,625,932 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

We don't see any clear sign of profit-making.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {πŸ”}

foxc, cancer, cells, pubmed, article, cell, nsclc, betacatenin, google, scholar, fig, cas, expression, lung, protein, knockdown, stem, properties, resistance, levels, central, cscs, overexpression, tumor, csclike, cisplatin, gefitinib, percentage, signaling, chen, forkhead, docetaxel, target, breast, wang, survival, yang, human, drug, oct, nanog, effects, binding, sox, abcg, analysis, box, luciferase, activity, nonsmall,

Topics {βœ’οΈ}

shbeta-catenin-expressing plasmid hsh054811–4-lvru6gp foxc1-expressing plasmid cs-x0042-lv217–01 pc9/g-shfoxc1-lv-beta-catenin nci-h1299-foxc1-lv-shbeta-catenin wnt/beta-catenin signaling pathway a549-shfoxc1-lv-beta-catenin pc9-foxc1-lv-shbeta-catenin small-cell lung cancer wnt/beta-catenin pathway atp-binding cassette subfamily beta-catenin-expressing plasmid nci-h1299-lv-foxc1 cells cytotoxic anti-cancer agents expressing plasmid hsh005629–33-lvru6rlp pc9/g-lv-shfoxc1 hui chenΒ &Β rong xu epithelial-mesenchymal transdifferentiation lv-shbeta-catenin lentivirus mutant beta-catenin promoters activating nf-kappab signaling beta-catenin knockdown decreased c-kit mediates chemoresistance beta-catenin knockdown enhanced nuclear beta-catenin protein nsclc wnt/beta-catenin beta-catenin promoter sequence lv-beta-catenin lentivirus beta-catenin overexpression rescued perform real-time pcr upregulate beta-catenin expression beta-catenin knockdown attenuated foxc1-expressing cell lines real-time pcr assays beta-catenin overexpression attenuated knockdown beta-catenin expression beta-catenin/tcf determines beta-catenin protein levels nci-h1299-lv-foxc1 promoting beta-catenin expression shbeta-catenin target sequence wnt signaling pathway stemness-related gene expression triple-negative breast cancer beta-catenin mediates vegf-notch signaling pathways a549-lv-shfoxc1 cells ultra low-attachment plates overcoming egfr-tki resistance target protein-bound dna full-length foxc1 cdna

Questions {❓}

  • Can lung cancer stem cells be targeted for therapies?

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC
         description:Accumulating evidence suggests that cancer stem cells (CSCs) play a critical role in tumor initiation, progression and therapy, and recent studies have indicated that Forkhead box C1 (FOXC1) is strongly associated with CSCs. This study investigates the regulatory effects of FOXC1 on CSC-like properties in non-small cell lung cancer (NSCLC). We analyzed FOXC1 expression in NSCLC using the Cancer Genome Atlas (TCGA) database on UALCANC and performed survival analyses of NSCLC patients on Human Protein Atlas. CSC-like properties were analyzed based on CSC marker-positive cell population, self-renewal ability, stemness-related gene expression, tumorigenicity and drug resistance. The percentage of CD133+ cells was analyzed by flow cytometric analysis. Self-renewal ability was detected by sphere-formation analysis. Real-time PCR, western blotting and immunohistochemical staining were employed to detect mRNA and protein levels. Tumorigenicity was determined based on a xenograft formation assay, and effects of FOXC1 on drug resistance were assessed by cell viability and apoptosis assays. Luciferase reporter and chromatin immunoprecipitation (ChIP) assays were used to investigate the binding of FOXC1 to beta-catenin promoter. FOXC1 expression was found to be elevated in NSCLC tissues and negatively correlated with patient survival. FOXC1 knockdown reduced CD133+ cell percentage, suppressed self-renewal ability, decreased expression of stemness-related genes (Oct4, NANOG, SOX2 and ABCG2) and inhibited NSCLC cell tumorigenicity in vivo. Moreover, FOXC1 knockdown increased cisplatin and docetaxel sensitivity and reduced gefitinib resistance, whereas FOXC1 overexpression enhanced CSC-like properties. Luciferase reporter and ChIP assays showed beta-catenin to be a direct transcriptional target of FOXC1. Furthermore, overexpression of beta-catenin reversed the CSC-like property inhibition induced by FOXC1 knockdown, and knockdown of beta-catenin attenuated the CSC-like properties induced by FOXC1 overexpression. This study demonstrates that FOXC1 induces CSC-like properties in NSCLC by promoting beta-catenin expression. The findings indicate that FOXC1 is a potential molecular target for anti-CSC-based therapies in NSCLC.
         datePublished:2018-09-06T00:00:00Z
         dateModified:2018-09-06T00:00:00Z
         pageStart:1
         pageEnd:12
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s13046-018-0894-0
         keywords:
            FOXC1
            Cancer stem cell-like properties
            Beta-catenin
            NSCLC
            Cancer Research
            Immunology
            Apoptosis
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0894-0/MediaObjects/13046_2018_894_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0894-0/MediaObjects/13046_2018_894_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0894-0/MediaObjects/13046_2018_894_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0894-0/MediaObjects/13046_2018_894_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0894-0/MediaObjects/13046_2018_894_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0894-0/MediaObjects/13046_2018_894_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0894-0/MediaObjects/13046_2018_894_Fig7_HTML.png
         isPartOf:
            name:Journal of Experimental & Clinical Cancer Research
            issn:
               1756-9966
            volumeNumber:37
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Sisi Cao
               affiliation:
                     name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
                     address:
                        name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhuo Wang
               affiliation:
                     name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
                     address:
                        name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xiujuan Gao
               affiliation:
                     name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
                     address:
                        name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Wenjuan He
               affiliation:
                     name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
                     address:
                        name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yue Cai
               affiliation:
                     name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
                     address:
                        name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hui Chen
               affiliation:
                     name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
                     address:
                        name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                        type:PostalAddress
                     type:Organization
                     name:The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province
                     address:
                        name:The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province, Wuhan, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Rong Xu
               affiliation:
                     name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
                     address:
                        name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                        type:PostalAddress
                     type:Organization
                     name:The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province
                     address:
                        name:The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province, Wuhan, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC
      description:Accumulating evidence suggests that cancer stem cells (CSCs) play a critical role in tumor initiation, progression and therapy, and recent studies have indicated that Forkhead box C1 (FOXC1) is strongly associated with CSCs. This study investigates the regulatory effects of FOXC1 on CSC-like properties in non-small cell lung cancer (NSCLC). We analyzed FOXC1 expression in NSCLC using the Cancer Genome Atlas (TCGA) database on UALCANC and performed survival analyses of NSCLC patients on Human Protein Atlas. CSC-like properties were analyzed based on CSC marker-positive cell population, self-renewal ability, stemness-related gene expression, tumorigenicity and drug resistance. The percentage of CD133+ cells was analyzed by flow cytometric analysis. Self-renewal ability was detected by sphere-formation analysis. Real-time PCR, western blotting and immunohistochemical staining were employed to detect mRNA and protein levels. Tumorigenicity was determined based on a xenograft formation assay, and effects of FOXC1 on drug resistance were assessed by cell viability and apoptosis assays. Luciferase reporter and chromatin immunoprecipitation (ChIP) assays were used to investigate the binding of FOXC1 to beta-catenin promoter. FOXC1 expression was found to be elevated in NSCLC tissues and negatively correlated with patient survival. FOXC1 knockdown reduced CD133+ cell percentage, suppressed self-renewal ability, decreased expression of stemness-related genes (Oct4, NANOG, SOX2 and ABCG2) and inhibited NSCLC cell tumorigenicity in vivo. Moreover, FOXC1 knockdown increased cisplatin and docetaxel sensitivity and reduced gefitinib resistance, whereas FOXC1 overexpression enhanced CSC-like properties. Luciferase reporter and ChIP assays showed beta-catenin to be a direct transcriptional target of FOXC1. Furthermore, overexpression of beta-catenin reversed the CSC-like property inhibition induced by FOXC1 knockdown, and knockdown of beta-catenin attenuated the CSC-like properties induced by FOXC1 overexpression. This study demonstrates that FOXC1 induces CSC-like properties in NSCLC by promoting beta-catenin expression. The findings indicate that FOXC1 is a potential molecular target for anti-CSC-based therapies in NSCLC.
      datePublished:2018-09-06T00:00:00Z
      dateModified:2018-09-06T00:00:00Z
      pageStart:1
      pageEnd:12
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s13046-018-0894-0
      keywords:
         FOXC1
         Cancer stem cell-like properties
         Beta-catenin
         NSCLC
         Cancer Research
         Immunology
         Apoptosis
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0894-0/MediaObjects/13046_2018_894_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0894-0/MediaObjects/13046_2018_894_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0894-0/MediaObjects/13046_2018_894_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0894-0/MediaObjects/13046_2018_894_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0894-0/MediaObjects/13046_2018_894_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0894-0/MediaObjects/13046_2018_894_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-018-0894-0/MediaObjects/13046_2018_894_Fig7_HTML.png
      isPartOf:
         name:Journal of Experimental & Clinical Cancer Research
         issn:
            1756-9966
         volumeNumber:37
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Sisi Cao
            affiliation:
                  name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
                  address:
                     name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhuo Wang
            affiliation:
                  name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
                  address:
                     name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xiujuan Gao
            affiliation:
                  name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
                  address:
                     name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Wenjuan He
            affiliation:
                  name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
                  address:
                     name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yue Cai
            affiliation:
                  name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
                  address:
                     name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hui Chen
            affiliation:
                  name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
                  address:
                     name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                     type:PostalAddress
                  type:Organization
                  name:The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province
                  address:
                     name:The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province, Wuhan, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Rong Xu
            affiliation:
                  name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
                  address:
                     name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                     type:PostalAddress
                  type:Organization
                  name:The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province
                  address:
                     name:The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province, Wuhan, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal of Experimental & Clinical Cancer Research
      issn:
         1756-9966
      volumeNumber:37
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
      address:
         name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
         type:PostalAddress
      name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
      address:
         name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
         type:PostalAddress
      name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
      address:
         name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
         type:PostalAddress
      name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
      address:
         name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
         type:PostalAddress
      name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
      address:
         name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
         type:PostalAddress
      name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
      address:
         name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
         type:PostalAddress
      name:The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province
      address:
         name:The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province, Wuhan, China
         type:PostalAddress
      name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
      address:
         name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
         type:PostalAddress
      name:The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province
      address:
         name:The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province, Wuhan, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Sisi Cao
      affiliation:
            name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
            address:
               name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
               type:PostalAddress
            type:Organization
      name:Zhuo Wang
      affiliation:
            name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
            address:
               name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
               type:PostalAddress
            type:Organization
      name:Xiujuan Gao
      affiliation:
            name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
            address:
               name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
               type:PostalAddress
            type:Organization
      name:Wenjuan He
      affiliation:
            name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
            address:
               name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
               type:PostalAddress
            type:Organization
      name:Yue Cai
      affiliation:
            name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
            address:
               name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
               type:PostalAddress
            type:Organization
      name:Hui Chen
      affiliation:
            name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
            address:
               name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
               type:PostalAddress
            type:Organization
            name:The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province
            address:
               name:The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province, Wuhan, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Rong Xu
      affiliation:
            name:School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology
            address:
               name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
               type:PostalAddress
            type:Organization
            name:The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province
            address:
               name:The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province, Wuhan, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
      name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
      name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
      name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
      name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
      name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
      name:The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province, Wuhan, China
      name:Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
      name:The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province, Wuhan, China

External Links {πŸ”—}(223)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {πŸ“¦}

  • Crossref

4.29s.